Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives

Sclerostin emerges as a novel target for bone anabolic therapy in bone diseases. Osteogenesis imperfecta (OI) and X-linked hypophosphatemia (XLH) are rare bone diseases in which therapeutic potential of sclerostin inhibition cannot be ignored. In OI, genetic/pharmacologic sclerostin inhibition promo...

全面介紹

書目詳細資料

Principais autores:	Tao Xiaohui, Luyao Wang, Xin Yang, Hewen Jiang, Ning Zhang, Huarui Zhang, Dijie Li, Xiaofei Li, Yihao Zhang, Shenghang Wang, Chuanxin Zhong, Sifan Yu, Meishen Ren, Meiheng Sun, Nanxi Li, Tienan Chen, Yuan Ma, Fangfei Li, Jin Liu, Yuanyuan Yu, Hua Yue, Zhenlin Zhang, Ge Zhang
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2024-07-01
叢編:	Journal of Orthopaedic Translation
主題:	Cardiovascular safety Loops Osteogenesis imperfecta (OI) Sclerostin Sclerostin inhibition Therapeutic perspectives
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2214031X24000469
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!